P/E Ratio
Higher than 49% of Consumer Cyclical sector peers
Updated 166h ago
Sector Performance
49th percentileRH
23.4x
Sector Median
23.8x
Sector Avg
36.2x
Deep Analysis
The current P/E ratio of 23.4x means that investors are paying $23.40 for every $1 of the company’s annual earnings.
This metric compares directly to the sector median of 23.2x, placing RH in the 51st percentile among Consumer Cyclical peers — essentially at the midpoint of valuation. No historical trend data is available, so both the year-over-year change and quarter-over-quarter change are listed as N/A, and only the single current value of 23.4x is reported. Because there is no trend to assess, the risk or opportunity from valuation hinges entirely on this single reading: at near-sector-median levels, the stock is neither expensive nor cheap relative to its peer group. This neutral positioning supports the overall NEUTRAL verdict, as the metric does not push decisively toward overvaluation or undervaluation.
Frequently Asked Questions
What does the P/E Ratio tell investors about RH?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
How does RH's P/E Ratio compare to its sector?
RH's P/E Ratio of 23.4x compares to a Consumer Cyclical sector median of 23.8x, placing it in the 49th percentile.
Who are RH's closest peers by P/E Ratio?
The closest Consumer Cyclical peers by P/E Ratio include: COLM (18.5x), BALL (17.9x), LI (17.8x), RCL (16.8x), CPRI (15.1x).
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master RH's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full RH research report →RH
23.4x
Sector Median
23.8x
Sector Avg
36.2x
How RH's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.